6550--Molecular Oncology-MSI Testing

SOL #: 36C26226Q0668Sources Sought

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
262-NETWORK CONTRACT OFFICE 22 (36C262)
Gilbert, AZ, 85297, United States

Place of Performance

Los Angeles

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 17, 2026
2
Response Deadline
Apr 23, 2026, 8:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), VISN 22 Network Contracting Office, is conducting a Request for Information (RFI)/Sources Sought to identify potential sources for Molecular Oncology-MSI Testing Reagent Cartridges on a reagent rental basis for the VA Greater Los Angeles Healthcare System. This RFI is for planning purposes only and is not a solicitation. Responses are due April 23, 2026.

Scope of Work

The VA seeks a system to perform in-house single gene molecular testing for Microsatellite Instability (MSI). The required system must meet the following salient characteristics:

  • Fully automated, ready-to-use reagents with no preparation.
  • Provide results in approximately 150 minutes.
  • No sample extraction required prior to use.
  • Capable of testing a minimum of 1 slice of FFPE tissue section.
  • Eliminate the use of external quality control.
  • Qualitative detection of mutations in 7 novel MSI loci (ACVR2A, BTBD7, DIDO1, MRE11, RYR3, SEC31A, SULF2). A "brand name or equal" product is specified, including the Biocartis Idylla MSI Assay (A0101/6), Idylla Console (P1010), and Idylla Instrument (P0010).

Contract & Timeline

  • Type: Request for Information (RFI) / Sources Sought
  • NAICS: 325413 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets) with a size standard of 1,250 Employees.
  • Set-Aside: None specified; market research is being conducted to identify qualified sources and their size classifications (e.g., SDVOSB, VOSB, WOSB, Large Business).
  • Response Due: Thursday, April 23, 2026, by 1:00 p.m. Pacific Time.
  • Published: April 17, 2026.

Submission Requirements

Interested sources should submit the following via email to Samuel.Han@va.gov:

  • Company name, address, point of contact, and UEI number.
  • Business size status (e.g., SDVOSB, VOSB, Hubzone, WOSB, Large Business) and confirmation of small business status under NAICS 325413.
  • Manufacturer or distributor status, including country of origin.
  • For small business distributors/resellers, details on any alterations, assembly, or modifications.
  • Information on existing GSA FSS, NAC, NASA SEWP, or other federal contracts for these items.
  • General pricing for market research purposes.
  • Capabilities demonstrating that "equal to items" meet all required salient characteristics.

Additional Notes

This RFI is for information and planning only and does not constitute a solicitation or an offer for a binding contract. Responders are responsible for all associated expenses. A future solicitation may be published based on the responses received.

People

Points of Contact

Samuel HanContract SpecialistPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Sources Sought
Posted: Apr 17, 2026
6550--Molecular Oncology-MSI Testing | GovScope